Noninvasive cardiac testing vs clinical evaluation alone in acute chest pain: A secondary analysis of the ROMICAT-II randomized clinical trial
JAMA Internal Medicine Nov 22, 2017
Reinhardt SW, et al. - Researchers contemplated the variations in outcomes with clinical evaluation and noninvasive testing (coronary computed tomographic angiography [CCTA] or stress testing) vs clinical evaluation alone, in patients with acute chest pain. A longer length of stay (LOS), more downstream testing, more radiation exposure, and greater cost without an improvement in clinical outcomes were yielded via negative biomarkers, and a nonischemic ECG result, noninvasive testing with CCTA or stress testing, in patients presenting to the Emergency Department (ED) with acute chest pain.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries